Newsletter | October 20, 2026

10.20.26 -- Reduce risk. Move Annex 1 forward.

Overview Of Single-Use System Integrity Assurance

Single-use system integrity is shaped long before a system enters operation. It depends on managing risk across the entire life cycle. Explore how materials, packaging, transport, installation, handling, and use influence sterility assurance.

How Does SUS Integrity Change Across The Drug Product Lifecycle?

Sterility assurance strategies must evolve as products move through development. Take a look at how phase-appropriate risk justification, validation, documentation, and lifecycle controls can strengthen sterility assurance while reducing the potential for rework and delays.

Characterization Of PFAS Extractables In Gas Filtration Devices

Sterilizing grade gas filters are critical to contamination control. Gain insight into how fluorinated membrane chemistries may introduce PFAS risks, as well as how extractables testing can support contamination control strategies.

VIDEO SHORTS

Single-Use Systems And Drug Product Manufacturing Challenges

EU GMP Annex 1 calls for contamination control across the full manufacturing process. Delve into why filter integrity testing alone is not enough and how evaluating fluid paths can strengthen quality.

Managing Risk Across The Single-Use System Lifecycle

Single-use system risk extends from initial design through installation and use. See how lifecycle-wide controls can strengthen contamination prevention and support regulatory readiness.

How Can We Help You Achieve Drug Product Risk Control?

Learn how you can strengthen contamination control by applying risk-based principles across the single-use system lifecycle, from design and validation through handling and use.